Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

204.6700 USD 0.4600 0.23%

As of 20:04:04 ET on 01/27/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 201.3400 High - Low: 206.7200 - 200.2090 Primary Exchange: NYSE Arca
Volume: 635,290 52-Week Range: 115.3117 - 206.7200 Beta vs SPSIBITR: 0.9990

ETF Chart for XBI

No chart data available.
  • XBI:US 204.6700
  • 1D
  • 1M
  • 1Y
204.2100
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-01-26) 204.0306
Assets (M) (on 2015-01-26) 1,734.2600
Shares out (M) 8.50
Market Cap (M) 1,739.69
% Premium 0.09
Average 52-Week % Premium -0.0027
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.4910
Dividend Yield (ttm) 0.98%

Performance for XBI

1-Month +9.30% 1-Year +34.17%
3-Month +22.43% 3-Year +40.58%
Year To Date +9.52% 5-Year +30.30%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 01/26/2015
Name Position Value % of Total
Foundation Medicine Inc 794,611 37,553,316 2.165%
Halozyme Therapeutics Inc 2,334,364 33,708,216 1.943%
Neurocrine Biosciences Inc 848,983 28,483,380 1.642%
NPS Pharmaceuticals Inc 596,311 27,388,564 1.579%
Ultragenyx Pharmaceutical Inc 449,599 26,171,158 1.509%
OPKO Health Inc 2,280,077 25,924,475 1.495%
Synageva BioPharma Corp 204,368 24,712,179 1.425%
Novavax Inc 3,238,040 24,609,104 1.419%
Alkermes PLC 342,826 24,464,063 1.411%
Array BioPharma Inc 3,132,011 24,445,346 1.409%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil